Table 2. Clinical (A.) and laboratory (B.) toxicity in patients treated with Ad5-Δ24-RGD by category and grade.
A. | |||||
---|---|---|---|---|---|
Body System | Toxicity Grades (NCI CTC V.3) | Total Occurrences | |||
1 | 2 | 3 | 4 | ||
Gastrointestinal | 61 | 34 | 6 | 0 | 101 |
Constitutional | 18 | 6 | 0 | 0 | 24 |
Pain | 10 | 8 | 1 | 0 | 19 |
Neurology | 4 | 4 | 0 | 0 | 8 |
Infection | 1 | 6 | 0 | 0 | 7 |
Dermatology/Skin | 0 | 4 | 1 | 0 | 5 |
Cardiac General | 2 | 2 | 0 | 0 | 4 |
Lymphatics | 3 | 1 | 0 | 0 | 4 |
Musculoskeletal | 3 | 1 | 0 | 0 | 4 |
Allergy/Immunology | 3 | 0 | 0 | 0 | 3 |
Syndromes | 0 | 2 | 0 | 0 | 2 |
Respiratory | 0 | 0 | 1 | 0 | 1 |
Renal/Genitourinary | 0 | 1 | 0 | 0 | 1 |
Blood/Bone Marrow | 1 | 0 | 0 | 0 | 1 |
Cardiac Arrhythmia | 1 | 0 | 0 | 0 | 1 |
B. | |||||
---|---|---|---|---|---|
Lab Tests | Toxicity Grades (NCI CTC V.3) | Total Occurrences | |||
1 | 2 | 3 | 4 | ||
Hemoglobin | 42 | 7 | 0 | 0 | 49 |
Hematocrit | 34 | 12 | 0 | 0 | 46 |
Glucose | 24 | 5 | 0 | 0 | 29 |
Potassium | 11 | 1 | 1 | 0 | 14 |
LDH | 8 | 2 | 0 | 0 | 10 |
Creatinine | 6 | 0 | 0 | 0 | 6 |
GGT | 4 | 1 | 0 | 0 | 5 |
WBC | 5 | 0 | 0 | 0 | 5 |
Sodium | 2 | 3 | 0 | 0 | 5 |
Alkaline Phosphatate | 5 | 0 | 0 | 0 | 5 |
Calcium | 2 | 2 | 0 | 0 | 4 |
Phosphorous | 2 | 2 | 0 | 0 | 4 |
Bicarbonate | 4 | 0 | 0 | 0 | 4 |
Chloride | 0 | 2 | 0 | 0 | 2 |
BUN | 2 | 0 | 0 | 0 | 2 |
Total Bilirubin | 1 | 0 | 0 | 0 | 1 |
Uric Acid | 0 | 0 | 0 | 0 | 0 |
Platelet | 0 | 0 | 0 | 0 | 0 |